Using OLFM4 knockdown studies, we discovered the critical role OLFM4 in the survival and drug resistance of primitive CML cells and demonstrated differences in OLFM4-mediated regulation of cell survival in CFCs and more primitive LTC-ICs (Fig. 7d). This evidence concerns the gene OLFM4 and chronic myelogenous leukemia, BCR-ABL1 positive.